Stay updated with breaking news from Pascale balducchi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Odimma Therapeutics, a biotechnology company specialized in personalized cancer immunotherapy announces a seed fundraising of €2 million in order to secure the preparation on its First-in-Man clinical ....
Touchlight and Odimma have entered into an agreement to develop and supply clinical material for Odimma's neoantigen program Touchlight, a biotechnology company pioneering enzymatic DNA production ....